Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Leukemia, Myeloid, Acute 35Myelodysplastic Syndromes 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Hematologic Neoplasms 14Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Lymphoma, Non-Hodgkin 12Myeloproliferative Disorders 11Lymphoma 11Leukemia, Myelomonocytic, Chronic 11Graft vs Host Disease 10Primary Myelofibrosis 9Leukemia 9Hodgkin Disease 9Leukemia, Lymphocytic, Chronic, B-Cell 7Anemia, Refractory, with Excess of Blasts 7Multiple Myeloma 6Leukemia, Biphenotypic, Acute 6Burkitt Lymphoma 5Polycythemia Vera 4Lymphoma, Follicular 4Leukemia, Myeloid 4Leukemia, Lymphoid 4Anemia, Aplastic 4Thrombocythemia, Essential 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precancerous Conditions 3Neoplasms, Plasma Cell 3Neoplasms 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoproliferative Disorders 3

Interventions

X-Rays 7Specimen Handling 7Phantoms, Imaging 7Magnetic Resonance Spectroscopy 6Nuclear Medicine Department, Hospital 5Biopsy 5Cisplatin 4Vincristine 3Fluorouracil 3Doxorubicin 3Carboplatin 3ulixertinib 2tipifarnib 2tazemetostat 2sodium thiosulfate 2selpercatinib 2palbociclib 2larotrectinib 2ivosidenib 2fludarabine 2erdafitinib 2ensartinib 2Vorinostat 2Temozolomide 2Sorafenib 2Oxaliplatin 2LY3023414 2Irinotecan 2Gemcitabine 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatoblastoma × Tacrolimus × 1 year × Clear all
NCT01804634 2026-03-13

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
60 enrolled
CNSGastrointestinalSarcoma

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡